Año: 2021
Journal Impact Factor (JIF): 4.3490
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 101/279 | Q2 | T2 | D4 |
| INFECTIOUS DISEASES | SCIE | 48/95 | Q3 | T2 | D6 |
Año: 2021
Journal Citation Indicator (JCI): 0,850
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 43/124 | Q2 | T2 | D4 | 65,73 |
| PHARMACOLOGY & PHARMACY | 123/361 | Q2 | T2 | D4 | 66,07 |
Año:
2021
CiteScore:
5,600
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Microbiology (medical) | 41/118 | Q2 | T2 | D4 |
| Immunology and Allergy | 87/200 | Q2 | T2 | D5 |
| Microbiology | 70/156 | Q2 | T2 | D5 |
| Immunology | 109/213 | Q3 | T2 | D6 |
SJR año:
2021
Factor de Impacto:
0,763
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Microbiology (medical) | 54/135 | Q2 | T2 | D4 |
| Microbiology | 74/174 | Q2 | T2 | D5 |
| Immunology and Allergy | 106/224 | Q3 | T2 | D5 |
| Immunology | 121/235 | Q3 | T2 | D6 |
| Agencia | Código de Proyecto |
|---|---|
| AMR Cross-Council Initiative through a grant from the Medical Research Council, a Council of UK Research and Innovation | MR/S004793/1 |
| AMR from Plan Nacional de I+D+i 2013- 2016 | - |
| AMR from the Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via the German Federal Ministry of Education and Research (BMBF) | 01KI1830 |
| European Commission ( JPI-EC-AMR) | - |
| European Commission (EXEDRA) | - |
| European Commission (JPIAMRACTION) | - |
| European Regional Development Fund 'A way to achieve Europe', Operative Program Intelligence Growth 2014-2020 | - |
| Global Antibiotic Research and Development Partnership (GARDP) | - |
| Innovative Medicines Initiative 1 and 2 Joint Undertaking | 115737; 115523; 820755 |
| Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades, Spanish Network for Research in Infectious Diseases | REIPI RD16/0016/0001; RD16/0016/0011 |
| Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via Instituto de Salud Carlos III | AC16/00076 |
| Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via the Medical Research Council in the UK | MR/S037640/1 |
| MRC | MR/S004793/1; MR/S037640/1 |
| National Institute for Health Research | NIHR200632 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Rodríguez-Baño, Jesús | Universidad de Sevilla; Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Instituto de Salud Carlos III (Spain) |
| 2 | Rossolini, Gian Maria | Università degli Studi di Firenze; Azienda Ospedaliera Careggi (Italy) |
| 3 | Schultsz, Constance | Universiteit van Amsterdam (Netherlands) |
| 4 | Tacconelli, Evelina | Università degli Studi di Verona (Italy) |
| 5 | Murthy, Srinivas | The University of British Columbia (Canada) |
| 6 | Ohmagari, Norio | National Center for Global Health and Medicine (Japan) |
| 7 | Holmes, Alison | Imperial College London (United Kingdom) |
| 8 | Bachmann, Till | Edinburgh Medical School (United Kingdom) |
| 9 | Goossens, Herman | Universiteit Antwerpen (Belgium) |
| 10 | Canton, Rafael | Instituto de Salud Carlos III; Instituto Ramón y Cajal de Investigación Sanitaria (Spain) |
| 11 | Roberts, Adam P. | Liverpool School of Tropical Medicine (United Kingdom) |
| 12 | Henriques-Normark, Birgitta | Karolinska University Hospital; Karolinska Institutet (Sweden) |
| 13 | Clancy, Cornelius J. | University of Pittsburgh (United States) |
| 14 | Huttner, Benedikt | Hôpitaux universitaires de Genève (Switzerland) |
| 15 | Fagerstedt, Patriq | Swedish Research Council (Sweden) |
| 16 | Lahiri, Shawon | Swedish Research Council (Sweden) |
| 17 | Kaushic, Charu | Canadian Institutes of Health Research; McMaster Immunology Research Centre (Canada) |
| 18 | Hoffman, Steven J. | Dahdaleh Institute for Global Health Research (Canada) |
| 19 | Warren, Margo | Access to Medicine Foundation (Netherlands) |
| 20 | Zoubiane, Ghada | International Centre for Antimicrobial Resistance Solutions (ICARS) (Denmark) |
| 21 | Essack, Sabiha | University of KwaZulu-Natal; International Centre for Antimicrobial Resistance Solutions (ICARS) (South Africa) |
| 22 | Laxminarayan, Ramanan | Center for Disease Dynamics (India) |
| 23 | Canadian Institutes of Health Research (Canada) |
